Location: Home
  • search
  • go
  • Relate News
  • 10/25/2019SMEI: Drug Spending Accounted for 34% of Chinese Healthcare Expenditur...
  • 10/25/2019CPA: Chinese Hospital Drug Monitor Report 2018
  • 10/25/2019Recent Executive Moves
  • 10/25/2019Chinese Transmucosal Delivery Drug Market to More Than Double by 2027
  • 10/24/2019Ambrx and NovoCodex in 2nd Deal to Develop & Commercialize Ambrx‘...
  • 10/24/2019China's $132 Billion Market Pushes Big Pharma Into Uncharted Territory
  • 10/24/2019Sino Biopharma Founders Makes Son Eric Tse A Major Shareholder with $3...
  • 10/24/2019NHSA Issues DRG Technical Guidelines and Grouping Plan
  • 10/24/2019Snapshot of BMI System Financial Performance in Q3/2019
  • 10/24/2019Johnson & Johnson Completes Two New Plants in China
  • 10/22/2019Harbin Pharma Considers Bid to Take Over US-based Vitamin Retailer GNC
  • 10/22/2019WuXi Biologics Boosts Investment into Irish Vaccine Plant
  • 10/22/2019China Is Striving for the World's Best, Cheapest Healthcare
  • 10/21/2019Roche Establishes Innovation Center in Pudong to Boost Medical R&D
  • 10/21/2019Centrient Pharma Initiates a Second Patent Litigation in India
  • 10/18/2019Recent Executive Moves
  • 10/18/2019CPA Hospital Drug Consumption Data Snapshot 2014-2018
  • 10/18/2019Merck Launches Seed Fund for Startups as It Opens Innovation Hut in Ch...
  • 10/18/2019SMEI: Top 20 Listed Chinese Pharma Companies by R&D Investment H1/...
  • 10/18/2019SMEI: Most Profitable Listed Chinese MedPharm Companies in H1/2019
  • 10/17/2019Tigermed Teams Up with Temasek To Launch $62M Biotech Fund
  • 10/17/2019NMPA Publishes 2018 Annual Report for Adverse Drug Reaction Monitoring
  • 10/16/2019China's Blueprint for Its Pharmaceutical Sector
  • 10/16/2019dMed Raises Nearly US$50M in Series B Financing
  • 10/15/2019Eisai's Fycompa Approved in China
  • 10/15/2019NMPA Issues New Announcement (2019#83) for Clinical Data Self-Inspecti...
  • 10/15/2019Lonza Tests Water in Chinese CDMO Sector
  • 10/15/2019I-Mab and MorphoSys Approved to Initiate Clinical Trials of TJ202 for ...
  • 10/14/2019Shionogi’s Thrombopoietin Receptor Agonist Lusutrombopag Granted Clin...
  • 10/14/2019Harbour BioMed Completes Phase 2 Chinese Study of HBM9036 for Dry Eye ...
  • Page:134/361 Total number of articles:10805: [First][<<] [132] [133] [134] [135] [136] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group